| scholarly article | Q13442814 |
| P50 | author | Roger F Butterworth | Q92140007 |
| P2093 | author name string | Mireille Bélanger | |
| Anne Chastre | |||
| Paul Desjardins | |||
| Bich N Nguyen | |||
| Elizabeth Beauchesne | |||
| P2860 | cites work | The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor | Q24563111 |
| CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system | Q28610458 | ||
| Cytokines in viral hepatitis | Q33697052 | ||
| Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. | Q34116455 | ||
| Extent of the acute phase response in fulminant hepatic failure | Q34379103 | ||
| Etanercept in rheumatoid arthritis | Q34388601 | ||
| TNF receptor subtype signalling: differences and cellular consequences | Q34565473 | ||
| Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 | ||
| Etiopathogenesis of acute hepatic failure: Eastern versus Western countries | Q35020784 | ||
| High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. | Q54586121 | ||
| Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists | Q56864876 | ||
| Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure | Q64380562 | ||
| Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists | Q70466614 | ||
| Role of Proinflammatory Cytokines in Acetaminophen Hepatotoxicity | Q71837634 | ||
| Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamol-induced hepatic necrosis | Q73504535 | ||
| Predictive value of serum-soluble CD154 in fulminant hepatic failure | Q81695028 | ||
| Protective effects of resveratrol against acetaminophen-induced toxicity in mice | Q83087991 | ||
| Acute liver failure: Summary of a workshop | Q36054934 | ||
| Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure | Q36145983 | ||
| Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory | Q36764958 | ||
| Innate immune response and hepatic inflammation | Q36989679 | ||
| Tumor necrosis factor antagonist mechanisms of action: a comprehensive review | Q37043901 | ||
| Etiology and prognosis of fulminant hepatitis in adults. | Q37282534 | ||
| Acute liver failure: mechanisms of immune-mediated liver injury | Q37759247 | ||
| Neuroinflammation in acute liver failure: mechanisms and novel therapeutic targets | Q37921872 | ||
| Etanercept: efficacy and safety for approved indications | Q37954714 | ||
| Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study | Q38381002 | ||
| Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse model | Q39901572 | ||
| Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure. | Q40303232 | ||
| Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. | Q41830915 | ||
| Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice | Q42453507 | ||
| Therapeutic evaluation of etanercept in a model of traumatic brain injury | Q42925025 | ||
| N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms. | Q43078904 | ||
| Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure | Q43136190 | ||
| Antioxidant and anti-inflammatory effects of mild hypothermia in the attenuation of liver injury due to azoxymethane toxicity in the mouse. | Q43144432 | ||
| Immunomodulatory effects of etanercept in an experimental model of spinal cord injury | Q46816845 | ||
| IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure | Q48401576 | ||
| Neurobiological characterization of an azoxymethane mouse model of acute liver failure | Q48606082 | ||
| Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. | Q48736659 | ||
| Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. | Q48896049 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver failure | Q970208 |
| inflammation | Q101991 | ||
| P304 | page(s) | e49670 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications | |
| P478 | volume | 7 |
| Q50295997 | A Prominent Role of Interleukin-18 in Acetaminophen-Induced Liver Injury Advocates Its Blockage for Therapy of Hepatic Necroinflammation. |
| Q50976128 | Acute liver injury attenuation of a novel recombinant sTNFR through blocking hepatic apoptosis. |
| Q48244940 | Ammonium increases Ca(2+) signalling and upregulates expression of Cav1.2 gene in astrocytes in primary cultures and in the in vivo brain |
| Q48013338 | Animal models of neuroinflammation secondary to acute insults originated outside the brain. |
| Q33870953 | Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice. |
| Q48511010 | Brown seaweeds protect against azoxymethane-induced hepatic repercussions through up-regulation of peroxisome proliferator-activated receptor gamma and attenuation of oxidative stress |
| Q37029990 | Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation |
| Q47371821 | Dietary lipophilic iron accelerates regional brain iron-load in C57BL6 mice. |
| Q47957219 | Differential function of natural killer cells in the liver graft perfusate of Korean population |
| Q40866699 | Effect and Mechanism of Portal Blood Stasis Removal on Intestinal Endotoxemia and Hepatic Ischemia Reperfusion Injury |
| Q35559905 | Effects of dexamethasone and cox inhibitors on intracranial pressure and cerebral perfusion in the lipopolysaccharide treated rats with hyperammonemia |
| Q98158743 | Extracellular gp96 is a crucial mediator for driving immune hyperactivation and liver damage |
| Q40677693 | GADD34 suppresses lipopolysaccharide-induced sepsis and tissue injury through the regulation of macrophage activation |
| Q41979567 | Improved Hepatoprotective Effect of Liposome-Encapsulated Astaxanthin in Lipopolysaccharide-Induced Acute Hepatotoxicity |
| Q36024993 | Induction of matrix metalloproteinase-1 by tumor necrosis factor-α is mediated by interleukin-6 in cultured fibroblasts of keratoconus |
| Q101476064 | Inhibition of aquaporin-3 in macrophages by a monoclonal antibody as potential therapy for liver injury |
| Q43694811 | Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure |
| Q38065088 | Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema. |
| Q27013022 | Neuroinflammation in hepatic encephalopathy: mechanistic aspects |
| Q41614589 | Neuron-derived CCL2 contributes to microglia activation and neurological decline in hepatic encephalopathy |
| Q34027245 | Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline |
| Q30965016 | Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure |
| Q35642846 | Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. |
| Q33947639 | Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence |
| Q33858381 | Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment. |
| Q44487620 | Proliferation of mouse liver stem/progenitor cells induced by plasma from patients with acute liver failure is modulated by P2Y2 receptor-mediated JNK activation. |
| Q26741218 | Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy |
| Q40096512 | TNFα induced up-regulation of Na+,K+,2Cl- cotransporter NKCC1 in hepatic ammonia clearance and cerebral ammonia toxicity |
| Q92504935 | The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy |
| Q52147776 | The concept of "the inflamed brain" in acute liver failure: mechanisms and new therapeutic opportunities. |
| Q38118579 | The liver-brain axis in liver failure: neuroinflammation and encephalopathy |
| Q59128671 | Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses |
| Q52653082 | Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure. |
| Q46649192 | Tumour necrosis factor-α-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6. |
| Q52147599 | What we know: the inflammatory basis of hepatic encephalopathy. |
Search more.